During the past decade, A. O. Ordine Mauriziano Umberto I conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "A. O. Ordine Mauriziano Umberto I" are "Coronary Artery Disease" (3 trials) and "Myocardial Ischemia" (3 trials). Many other conditions were trialed in "A. O. Ordine Mauriziano Umberto I" in a lesser frequency.

Most popular intervention types in "A. O. Ordine Mauriziano Umberto I" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "AmM APTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials), "AmM FORTITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials) and "AmM MAGNITUDE Bioresorbable Drug-Eluting Coronary Scaffold" (1 trials). Other intervention names were less common.

The vast majority of trials in "A. O. Ordine Mauriziano Umberto I" are 3 trials for "All" genders.

Currently, there are NaN active trials in "A. O. Ordine Mauriziano Umberto I". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in A. O. Ordine Mauriziano Umberto I, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in A. O. Ordine Mauriziano Umberto I, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".